Mamoru Mutai

546 citations

44 papers · 443 indexed · h-index 14

Impact in

Cancer Research
- Carcinogens and Genotoxicity Assessment
Pharmacology
- Pharmacogenetics and Drug Metabolism

Papers in

Cancer Research 10
- Carcinogens and Genotoxicity Assessment 7
Pharmacology 5
- Drug-Induced Hepatotoxicity and Protection 4

Co-authors: Toshimi Usui Shigeru Hisada Kiyoshi Kobayashi Masae Tatematsu Nobuyuki Ito Carl L. Alden Keith A. Soper B. D. McCullough
Journals: Toxicologic Pathology (7 papers)Carcinogenesis (6 papers)Cancer Letters (2 papers)Brain Research (1 paper)Archives of Toxicology (1 paper)
Partner nations: Japan United States United Kingdom

In The Last Decade

Mamoru Mutai

42 papers receiving 410 citations

Peers

Countries citing papers authored by Mamoru Mutai

Since Specialization

Citations

This map shows the geographic impact of Mamoru Mutai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Mutai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Mutai more than expected).

Fields of papers citing papers by Mamoru Mutai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mamoru Mutai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Mutai. The network helps show where Mamoru Mutai may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mamoru Mutai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mamoru Mutai Line = papers co-authored together Mamoru Mutai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	O-24 Independent regulation of intrarenal angiotensin receptors expression during the development of cyclosporine A-induced hypertension(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting) The Journal of Toxicological Sciences ·Ina Schr�der, ヨウコウチカワ, Hiroko Kondo, Andressa Miliana Alves Pinto, Hiroshi Fujisaki, Rishat R. Shaimardanov, Genfu Chen, Paul M. Silber, Mamoru Mutai, Naohisa Tsutsui	2004	2
2	O-23 Cisplatin- and nedaplatin- induced nephrotoxicity and their renal accumulation in rats(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting) The Journal of Toxicological Sciences ·ヨウコウチカワ, Shun-ichiro Ishii, Hiroshi Shibata, Miyako Okada, Yoshimi Inoue, Jiro Sugimoto, Zhengya Yang, Akio Sugiyama, Mamoru Mutai	2004	2
3	Decreased Expression of Bcl‐x Protein during Hepatocarcinogenesis Induced Exogenously and Endogenously in Rats Japanese Journal of Cancer Research ·Yutaka Hatanaka, Dai Nakae, Mamoru Mutai, Kaoru Hashizume, J Tobin, Noriaki Kinoshita, Yoichi Tani, Gen‐ichi Danno, Shigeo Ohta, Yoichi Konishi, Hitoshi Ashida	2001	5
4	Dose‐dependent Promoting Effects of Catechol on Glandular Stomach Carcinogenesis in BALB/c Mice Initiated with N‐Methyl‐N‐nitrosourea Japanese Journal of Cancer Research ·Kiyoshi Kobayashi, Nobuyuki Shimizu, Tetsuya Tsukamoto, Ken-ichi Inada, Hayao Nakanishi, Kazuhiro Goto, Mamoru Mutai, Masae Tatematsu	1997	7
5	Effects of carbon tetrachloride administration on initiation of liver cell foci by the non-hepatocarcinogens N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) and benzo(a)pyrene (B(a)P) Cancer Letters ·Kiyoshi Kobayashi, Mamoru Mutai, Kazuhiro Goto, Ken-ichi Inada, Tetsuya Tsukamoto, Hayao Nakanishi, Masae Tatematsu	1997	11
6	Modifying Influence of Swine Serum‐induced Liver Fibrosis on Development of Preneoplastic Lesions in Rat Liver Japanese Journal of Cancer Research ·Zhang Beidong, Toshio Kato, Mamoru Mutai, Keisuke Ozaki, Tian Hong Yang, Dae Joong Kim, Francesca Placidi, Makoto Asamoto, Nobuyuki Ito, Hiroyuki Tsuda	1996	1
7	Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver Carcinogenesis ·Hiroyuki Tsuda, Makoto Asamoto, E.G. Voronin, Takaaki Hori, Tomonori Ota, Francesca Placidi, Nobuaki Uehara, Dae Joong Kim, Vladimir Krutovskikh, Nobuo Takasuka, V.N. Gaitonde, Mamoru Mutai, Masae Tatematsu, Hiroshi Yamasaki	1996	15
8	Development of ethinylestradiol(EE)-induced testicular atrophy in rats: involvement of apoptosis in EE-induced spermatogenic cell death. Journal of Toxicologic Pathology ·V.N. Gaitonde, 政人植村, Micah Farver, Kazuhiro Goto, Jiro Sugimoto, Mamoru Mutai	1996	2
9	ORIGIN OF SERUM ALP ISOZYME AND IT CHANGE DURING THE FASTING IN BEAGLE DOGS. The Journal of Toxicological Sciences ·Yoshimi Inoue, Yoshiki Terazono, Naoya Masutomi, Roger Marois, Mamoru Mutai	1995	0
10	ADDITIVE ACTION OF FIVE HETEROCYCLIC AMINES IN TERMS OF INDUCTION OF GTS-P POSITIVE SINGLE CELLS AND FOCI IN RAT LIVER-CORRELATION WITH DNA ADDUCT FORMATION Journal of Toxicologic Pathology ·Satoru Takahashi, Ryohei Hasegawa, Mamoru Mutai, Nobuyuki Ito, Masako Ochiai, Minako Nagao, Takashi Sügimura	1994	4
11	Modification of BHA forestomach carcinogenesis in rats: inhibition by diethylmaleate or indomethacin and enhancement by a retinoid Carcinogenesis ·Masa‐Aki Shibata, Baher A. El Kalioubi, Atsuko Masuda, Jun Whee Lee, Mamoru Mutai, Nobuyuki Ito	1993	14
12	Effects of phenolic antioxidants in low dose combination on forestomach carcinogenesis in rats pretreated with N-methyl-N'-nitro-N-nitrosoguanidine. PubMed ·Masao Hirose, Mamoru Mutai, Satoru Takahashi, Mayumi Yamada, Shoji Fukushima, Nobuyuki Ito	1991	20
13	Enhancing effects of various gastric carcinogens on development of pepsinogen-altered pyloric glands in rats Carcinogenesis ·Huu Duc Duong, Keisuke Ozaki, Mamoru Mutai, Muhammad Lucky Hermanto, Chie Furihata, Nobuyuki Ito	1990	14
14	Modulatory interaction between initial clofibrate treatment and subsequent administration of 2-acetylaminofluorene or sodium phenobarbital on glutathione S-transferase positive lesion development Cancer Letters ·Mamoru Mutai, Masae Tatematsu, Stefanie Land-Hilbert, Zhang Beidong, N. Ito	1990	5
15	Pyloric gland phenotypic expression of gastric cancers developing in the rat fundic glandular stomach Carcinogenesis ·Masae Tatematsu, Tsutomu Katsuyama, Mamoru Mutai, Emiko Asakawa, Nobuyuki Ito	1989	17
16	Synergistic Effects of Low‐dose Hepatocarcinogens in Induction of Glutathione S‐Transferase P‐positive Foci in the Rat Liver Japanese Journal of Cancer Research ·Ryohei Hasegawa, Mamoru Mutai, Surya Hutani, Hiroyuki Tsuda, Shuji Yamaguchi, Nobuyuki Ito	1989	17
17	B31 DETECTION OF HEPATOCARCINOGENIC POTENTIAL OF 5 CHEMICALS BY A MEDIUM-TERM BIOASSAY SYSTEM The Journal of Toxicological Sciences ·Atsushi Nakamura, Shuji Yamaguchi, Mamoru Mutai, Hiroyuki Tsuda, Hugo Aristizábal Correa, Nobuyuki Ito, Yong‐Soon Lee	1988	0
18	Low Tumorigenic Response to 3,2′‐Dimethyl‐4‐aminobiphenyl Administration in the Prostate of Rats Castrated at Birth Japanese Journal of Cancer Research ·Tomoyuki Shirai, Yoshiaki Tagawa, Osamu Taguchi, Etsuo Ikawa, Mamoru Mutai, Shoji Fukushima, Nobuyuki Ito	1988	1
19	Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine Carcinogenesis ·Tsuneo Masui, Tomoyuki Shirai, Satoru Takahashi, Mamoru Mutai, Shoji Fukushima	1988	15
20	Cell-specific hypomethylation of the pepsinogen gene in pepsinogen-producing cells Biochemical and Biophysical Research Communications ·Ren Yong, Kazumasa Miki, Masae Tatematsu, Takakazu Mizuno, Mamoru Mutai, Chie Furihata, Yoshikazu Ichihara, Takeshi Ishihara, Masao Tanji, Hiroshi Oka, Shagoofi Anjum, Takayuki Takahashi, J J Rast, Kenji Takahashi	1988	5

About Mamoru Mutai

Mamoru Mutai is a scholar working on Cancer Research, Pharmacology, Hepatology, Oncology and Molecular Biology, having authored 44 papers that have together received 443 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (7 papers), Glutathione Transferases and Polymorphisms (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Liver physiology and pathology (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Digestive system and related health (3 papers). The work is most often cited by research in Cancer Research (140 citations), Pharmacology (36 citations), Hepatology (29 citations), Oncology (93 citations) and Health, Toxicology and Mutagenesis (45 citations). Mamoru Mutai has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshimi Usui, Shigeru Hisada, Kiyoshi Kobayashi, Masae Tatematsu, Nobuyuki Ito, Carl L. Alden, Keith A. Soper, B. D. McCullough, Chie Furihata and Shoji Fukushima. Their work appears in journals such as Toxicologic Pathology, Carcinogenesis, Cancer Letters, Brain Research and Archives of Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact